Skip to content
Travatan(travoprost)
DuoTrav, Izba, Travatan (travoprost) is a small molecule pharmaceutical. Travoprost was first approved as Travatan on 2001-03-16. It is used to treat open-angle glaucoma in the USA. It has been approved in Europe to treat ocular hypertension and open-angle glaucoma.
Download report
Favorite
Novartis Pharmaceuticals
Commercial
Therapeutic Areas
Therapeutic Area
MeSH
eye diseasesD005128
Trade Name
FDA
EMA
Travatan (generic drugs available since 2013-03-01, discontinued: Izba)
Drug Products
FDA
EMA
New Drug Application (NDA)
New Drug Application (NDA)
Abbreviated New Drug Application (ANDA)
Abbreviated New Drug Application (ANDA)
Travoprost
Tradename
Company
Number
Date
Products
TRAVATAN ZNovartisN-021994 RX2006-09-21
1 products, RLD, RS
Show 2 discontinued
Labels
FDA
EMA
Brand Name
Status
Last Update
travatan zNew Drug Application2020-05-15
travoprostANDA2022-12-15
Indications
FDA
EMA
Indication
Ontology
MeSH
ICD-10
open-angle glaucomaEFO_0004190D005902H40.1
Agency Specific
FDA
EMA
No data
Patent Expiration
Patent
Expires
Flag
FDA Information
Travoprost, Travatan Z, Novartis
82682992029-10-13DP
83236302027-09-20DP
83889412027-09-20DP
Travoprost, Izba, Novartis
81785822029-10-10DP
87227352029-10-10DP
87541232029-05-19DP
91445612029-03-13DP
ATC Codes
S: Sensory organ drugs
S01: Ophthalmologicals
S01E: Antiglaucoma preparations and miotics
S01EE: Prostaglandin analogues, antiglaucoma drugs and miotics
S01EE04: Travoprost
HCPCS
No data
Clinical
Clinical Trials
130 clinical trials
View more details
Mock data
Subscribe for the real data
Indications Phases 4
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Ocular hypertensionD009798EFO_1001069H40.01133032985
Open-angle glaucomaD005902EFO_0004190H40.11026251071
GlaucomaD005901EFO_0000516H4024629546
Intraocular pressureD007429314
Angle-closure glaucomaD015812112
VitiligoD014820EFO_0004208L8011
Excimer lasersD05401811
HyperemiaD006940EFO_0003822H34.8211
Low tension glaucomaD057066EFO_1001022H40.1211
Macular edemaD00826911
Show 2 more
Indications Phases 3
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Exfoliation syndromeD017889EFO_0004235112
Indications Phases 2
No data
Indications Phases 1
No data
Indications Without Phase
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Neovascular glaucomaD015355EFO_100106011
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
Drug common nameTRAVOPROST
INNtravoprost
Description
Travoprost is the isopropyl ester of prostaglandin F2alpha in which the pentyl group is replaced by a 3-(trifluoromethyl)phenoxymethyl group. A synthetic analogue of prostaglandin F2alpha, ophthalmic solutions of travoprost are used as a topical medication for controlling the progression of open-angle glaucoma and ocular hypertension, by reducing intraocular pressure. It is a pro-drug; the isopropyl ester group is hydrolysed by esterases in the cornea to the biologically active free acid, fluprostenol. It has a role as an antiglaucoma drug, an antihypertensive agent, a prodrug, an ophthalmology drug and a prostaglandin receptor agonist. It is a prostaglandins Falpha, a member of (trifluoromethyl)benzenes and an isopropyl ester. It is functionally related to a fluprostenol.
Classification
Small molecule
Drug classprostaglandins
Image (chem structure or protein)
Structure (InChI/SMILES or Protein Sequence)
CC(C)OC(=O)CCC/C=C\C[C@H]1[C@@H](O)C[C@@H](O)[C@@H]1/C=C/[C@@H](O)COc1cccc(C(F)(F)F)c1
Identifiers
PDB
CAS-ID157283-68-6
RxCUI283809
ChEMBL IDCHEMBL1200799
ChEBI ID746859
PubChem CID5282226
DrugBankDB00287
UNII IDWJ68R08KX9 (ChemIDplus, GSRS)
Target
Agency Approved
No data
Alternate
No data
Variants
Clinical Variant
No data
Financial
Travoprost - Novartis
$
£
Mock data
Subscribe for the real data
Mock data
Subscribe for the real data
Tabular view
Trends
PubMed Central
Top Terms for Disease or Syndrome:
Mock data
Subscribe for the real data
Additional graphs summarizing 1,654 documents
View more details
Safety
Black-box Warning
No Black-box warning
Adverse Events
Top Adverse Reactions
Mock data
Subscribe for the real data
5,418 adverse events reported
View more details